Syncom Formulations

Mumbai, India Founded: 1995 • Age: 31 yrs
Pharmaceutical formulations are manufactured and exported in various dosage forms.
Annual revenue $53.5M Latest available
Total funding - Funding intelligence
Employees 2120 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Syncom Formulations

Syncom Formulations is a company based in Mumbai (India) founded in 1995. The company has 2,120 employees as of March 31, 2024. Syncom Formulations offers products and services including Pharmaceutical Formulations and Regulatory Compliance Services.

  • Headquarter Mumbai, India
  • Employees 2120 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Syncom Formulation (India) Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $53.49 M (USD)
    76.43
    as on Mar 31, 2025
  • Net Profit
    $5.79 M (USD)
    95.28
    as on Mar 31, 2025
  • EBITDA
    $5.51 M (USD)
    80.17
    as on Mar 31, 2025
  • Latest Funding Round
  • Investors
  • Employee Count
    2120

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Syncom Formulations

Syncom Formulations is a publicly listed company on the NSE with ticker symbol SYNCOMF in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: SYNCOMF · Sector: Health technology · India

Products & Services of Syncom Formulations

Syncom Formulations offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Regulatory Compliance Services.

Primary

Formulations are developed for pharmaceutical uses, as derived from the company's name and website presence.

Services related to regulatory compliance are offered, based on the emphasis seen on the website.

Funding Insights of Syncom Formulations

Investments & Acquisitions by Syncom Formulations

Investments

Financial Statements - Syncom Formulations

Syncom Formulations Comparisons

+
Add Comparison
Available on Premium

Competitors of Syncom Formulations

Latest news on Syncom Formulations

Frequently Asked Questions about Syncom Formulations

Syncom Formulations was founded in 1995.

Syncom Formulations is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

As of Mar 31, 2024, the latest employee count at Syncom Formulations is 2,120.

Annual revenue of Syncom Formulations is $53.49M as on Mar 31, 2025.

Syncom Formulations was established in 1995 in Mumbai, India, within the pharmaceutical sector. Branded generics are produced in multiple formats, including tablets, capsules, liquid orals, vials, ampoule injections, dry vial injections, dry syrups, ointments, and inhalers. Operations focus on formulation manufacturing and export, supporting global distribution from the Indian base.

Syncom Formulations offers Pharmaceutical Formulations and Regulatory Compliance Services.

Yes, Syncom Formulations is publicly traded on NSE under the ticker symbol SYNCOMF.

The ticker symbol of Syncom Formulations is SYNCOMF on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available